Compare Aurora Cannabis Inc (ACB) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aurora Cannabis Inc vs Quest Diagnostics Inc — how do they compare? Aurora Cannabis Inc trades at $3.49 (market cap $223.59M), while Quest Diagnostics Inc trades at $237.5 (market cap $26.21B). The key difference: Quest Diagnostics Inc is far larger — about 117.2× Aurora Cannabis Inc's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.
| ACB | DGX | |
|---|---|---|
Market Cap | $223.59M | $26.21B |
Sector | Health | Health |
52-Week High | $6.23 | $238.50 |
52-Week Low | $2.58 | $173.49 |
Enterprise Value | $168.09M | $31.97B |
Dividend Yield | — | 1.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
